DoD Invests in Sangart’s MP4 Molecule Development for Trauma Applications

The Department of Defense awarded a $1.1 million grant to Sangart, Inc. to fund pre-clinical development of the MP4 molecule, a product that can provide “targeted oxygen delivery to the capillaries in severely injured trauma patients,” according to Sangart’s press release.

The award is being issued as part of the Defense Medical Research and Development Program, which provides grants in support of research designed to advance state-of-the-art solutions for world-class medical care for U.S. soldiers.

Leave a Reply